Colombier Acquisition Corp III
CLBR.WS · NYSE
CLBR.WS key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 30.48K
- Volume
- 22.50K
- Open price
- $0.5101
- High today
- $0.5101
- Low today
- $0.4301
- 52 Week high
- $1.09
- 52 Week low
- $0.40
Colombier Acquisition Corp III (CLBR.WS) at a glance
Colombier Acquisition Corp III (CLBR.WS) last traded at $0.49.
Today the stock has traded between $0.4301 and $0.5101. The current price is 13.9% above the day's low and 3.9% below its high.
Volume so far is 22.50K shares, below the average of 30.48K shares a day.
Over the past year Colombier Acquisition Corp III has ranged from $0.40 to $1.09, and now sits 13% of the way up that range.
Most active stocks
Highest trading volume today
- BURUNuburu$0.287−22.79%
- INTCIntel$65.76−28.58%
- SLGBSmart Logistics Global$0.3051+48.97%
- AXXAExxe Group$0.0006+50.00%
- RDARRaadr$0.0002+0.00%
- SOXLDirexion Shares ETF Trust$77.05−24.75%
- HUBCHub Cyber Security$0.1134−16.00%
- RWAXTAP Real Estate Technologies$0.0002+0.00%
- NVDANVIDIA$204.64−4.20%
- NVDGraniteShares ETF Trust$4.43+8.19%
- SPCXSpace Exploration Technologies$134.69−6.39%
- GTVHGolden Triangle Ventures$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$38.38+0.27%
- BHAIUBHAV Acquisition Corp II$9.98+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.05%
- LYCALycia Therapeutics$26.40−4.80%
- DAVIDAVION HEALTHCARE$1.68−37.55%
- TCXBTCGX Acquisition Corp. II$10.14−0.66%
- CTYCITY THERAPEUTICS$20.71−6.46%
- IAMIambic Therapeutics$13.43−5.95%
- AMROAmaero$5.56−3.81%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.17−0.39%
- TRXBTRex Bio$13.74+1.63%
- RTSNRetension Pharmaceuticals$11.36−3.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.